You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Invasive Fungal Infections -- A Growing Threat: Meeting the Challenge With 21st Century Solutions

  • Authors: Matteo Bassetti, MD, PhD; Oliver A. Cornely, MD, FECMM, FACP, FIDSA, FAAM; J. Peter Donnelly, BSc, PhD, FRCPath
  • CME Released: 10/11/2022
  • Valid for credit through: 10/11/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US infectious disease specialists, critical care specialists, pharmacists, and other healthcare professionals caring for patients at risk for invasive fungal infections.

The goal of this activity is for learners to be better able to care for patients at risk for invasive (severe) fungal infections as to the epidemiology, burden, and therapeutic options for the prevention and treatment of these potentially life-threatening infections.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Burden of invasive fungal infections
    • Current landscape of antifungal therapeutics
    • Novel therapeutic approaches for the treatment and prophylaxis of severe fungal infections


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Matteo Bassetti, MD, PhD

    Professor of Infectious Diseases
    University of Genoa
    Genoa, Italy

    Disclosures

    Matteo Bassetti, MD, PhD, has the following relevant financial relationships: 
    Consultant or advisor for: Cidara; Merck Sharp Dohme
    Speaker or member of speakers bureau for: Cidara; Menarini; Merck Sharp Dohme; Pfizer, Inc.; Shionogi; Sobi
    Research funding from: Cidara; Menarini; Merck Sharp Dohme; Pfizer, Inc.; Shionogi

Faculty

  • Oliver A. Cornely, MD, FECMM, FACP, FIDSA, FAAM

    Professor of Translational Research
    University Hospital Cologne
    Cologne, Germany

    Disclosures

    Oliver A. Cornely, MD, FECMM, FACP, FIDSA, FAAM, has the following relevant financial relationships: 
    Consultant or advisor for: AbbVie; Amplyx; Biocon; Biosys; Cidara; Da Volterra; Gilead Sciences; Matinas; Medpace; Menarini; Molecular Partners; MSGERC; Noxxon; Octapharma; Pardes; PSI; SCYNEXIS; Seres
    Speaker or member of speakers bureau for: Actelion; Allecra; Cidara; Entasis; IQVIA; Janssen; Medpace; Paratek; PSI; Pulmocide; Shionogi
    Research funding from: Amplyx; Basilea; BMBF; Cidara; F2G; Gilead Sciences; Matinas; Medpace; Merck Sharp Dohme; Mundipharma; Octapharma; Pfizer, Inc.; SCYNEXIS
    Patent beneficiary of: A patent at the German Patent and Trademark Office (DE 10 2021 113 007.7)
    Stock options from: CoRe Consulting
    Other: Honoraria for lectures from: Abbott; Al-Jazeera Pharmaceuticals; Astellas; Grupo Biotoscana/United Medical/Knight; Hikma; medupdate; Merck/Merck Sharp Dohme; Mylan; Pfizer, Inc.; Payment for expert testimony from: Cidara

  • J. Peter Donnelly, BSc, PhD, FRCPath

    Retired From Department of Hematology
    Radboudumc
    Nijmegen, the Netherlands

    Disclosures

    J. Peter Donnelly, BSc, PhD, FRCPath, has the following relevant financial relationships: 
    Consultant or advisor for: F2G; Gilead Sciences; Pfizer, Inc.
    Speaker or member of speakers bureau for: Gilead Sciences; Pfizer, Inc.

Editors

  • Alessia Piazza, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Alessia Piazza, PhD, has no relevant financial relationships.

  • Chii Shyang Fong, PhD

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Chii Shyang Fong, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Invasive Fungal Infections -- A Growing Threat: Meeting the Challenge With 21st Century Solutions

Authors: Matteo Bassetti, MD, PhD; Oliver A. Cornely, MD, FECMM, FACP, FIDSA, FAAM; J. Peter Donnelly, BSc, PhD, FRCPathFaculty and Disclosures

CME Released: 10/11/2022

Valid for credit through: 10/11/2023

processing....